Evenamide

DB18775InvestigationalSmall molecule

Evenamide: Overview.

Mechanism: Pharmacologically active on Voltage-gated sodium channel alpha subunit
Curator reviewed
Formula / weight: C₁₆H₂₆N₂O₂ · 278.396 g/mol (avg)
Code names: NW-3509

Resolves to

Compound

Structure

InChIKeyGRHBODILPPXVKN-UHFFFAOYSA-NSMILESCCCCOC1=CC=CC(CCNCC(=O)N(C)C)=C1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Evenamide, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.